Paclitaxel-Carboplatin-Bevacizumab +/- Nitroglycerin in Metastatic Non-Squamous-Non-Small Cell Lung Cancer
Condition(s):Non Small Cell Lung CancerLast Updated:September 28, 2020Completed
Hide Studies Not Open or Pending
Condition(s):Non Small Cell Lung CancerLast Updated:September 28, 2020Completed
Condition(s):Carcinoma, Non-Small-Cell LungLast Updated:September 29, 2020Completed
Condition(s):NSCLCLast Updated:July 12, 2023Recruiting
Condition(s):Carcinoma, Non-small Cell LungLast Updated:April 30, 2019Terminated
Condition(s):Carcinoma, Non-Small Cell LungLast Updated:December 21, 2021Active, not recruiting
Condition(s):Carcinoma, Non-Small-Cell LungLast Updated:June 5, 2023Recruiting
Condition(s):COVID-19; Pulmonary FibrosisLast Updated:February 15, 2023Completed
Condition(s):NSCLCLast Updated:March 27, 2023Recruiting
Condition(s):Non-Small Cell Lung CancerLast Updated:October 27, 2023Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.